Photosensitizer prodrug-induced protein expression in cancer cells

Diplôme Thèse Photosensitizer prodrug-induced protein expression in cancer cells eng 2022-09-30 2022-10-18 author Sansaloni Pastor Sara 891700 director Lange Norbert 135650 155 10.13097/archive-ouverte/unige:165216 urn:nbn:ch:unige-1652165 Sc. 5691 Nowadays, cancer is a well-recognized and prevalent cause of death worldwide, accounting for nearly 10 million deaths in 2020. Following its relevant socioeconomic consequences, significant efforts were focused on developing therapies to confront and diagnose this pathology. However, to date, cancer incidence and mortality remain high. Consequently, new approaches have been developed. Among them, photodynamic therapy (PDT) has shown significant potential for the treatment and detection of cancer. This technique is based on the administration of a molecule (photosensitizer), and then, after accumulation, light is applied, which will activate the photosensitizer, producing fluorescence. In addition, in the presence of oxygen, this process could lead to the accumulation of reactive oxygen species, leading to cellular death. Among the most promising prodrugs employed nowadays, 5-ALA mediated PpIX gathers major recognition and promise. This molecule (5-ALA) is preferentially metabolized in cancer cells. Aiming to further characterize and refine 5-ALA-mediated PpIX, for the first time, we evaluated the consequences of this treatment in cancer cells to identify significant changes in protein expression, either implicated in 5-ALA metabolism or constituting interesting targets. Along the present thesis, we compared bladder cancer cells (T24) treated with 5-ALA, SA (inhibitor of HMBS) to non-treated cells, employing proteomic mass spectrometry analysis. Interestingly, our results demonstrated that either porphyrin upregulation (PpIX accumulation) or 5-ALA accumulation (5-ALA + SA treatment) induced a significant change in several enzymes implicated in the metabolism of this pro-drug. More interestingly, each condition opposite changes on protein expression, either upregulating or downregulating those enzymes involved in heme degradation and synthesis pathway. In parallel to the significant changes of the 5-ALA metabolism-related enzymes, we also identified several promising targets overexpressed after 5-ALA treatment. Indeed, OR1B1, AGRN, NCSTN, TMEM, and SLC44A1 were significantly upregulated after 5-ALA supply and without light activation. Mass spectrometry data was then further validated by immunofluorescence in T24, A549, and PC3 cells. Importantly, the transmembrane nature of these proteins is a relevant property, facilitating the detection and targeting of cancer cells with intact cellular membranes. In conclusion, our results demonstrate for the first time a potential regulatory mechanism modulating both the synthesis and degradation of heme, preventing the accumulation of toxic intermediates (ie., PpIX, heme, or PBG). Indeed, to our knowledge, this is the first time this mechanism has been endorsed with significant experimental data. Consequently, we hypothesized that upon 5-ALA exogenous supply, the described changes in protein expression support cell viability. Along the second aim, we also demonstrated that 5-ALA treatment regulates the expression of several proteins non-related to the porphyrin pathway. These can be used to develop a new therapy independent of light stimulation further. Photodynamic therapy Cancer Oncology Photodiagnosis Protein Proteomics Heme OR1B1 AGRN Protein expression Metabolic Heme pathway Dewey 615 31 Section des sciences pharmaceutiques 17 false 883 Technologie pharmaceutique e32965b7-d52c-4d81-9688-026f6cc338b2 Thesis Restricted sansalonipastor_thesis_imprimatour.pdf 4005509 application/pdf Private 2023-10-01 6dc0e74c2a33cbef7014e7e69e4b08091dc39677d712a3c8ce436cbdd004a6ad 392a40f1-3d21-4ad5-9e77-dda75cf38d73 Imprimatur Public imprimatuer.pdf 1659548 application/pdf d688462e07054e86d2829734c86474faf476bb3b107456c6475fb65af58bb9a5 restrictedAccess Faculté des sciences / Section des sciences pharmaceutiques

Title	Published in	Access level	OA Policy	Year	Views	Downloads

Photosensitizer prodrug-induced protein expression in cancer cells				2022	465	7

Archive ouverte UNIGE

Sansaloni Pastor, Sara

account_balance Affiliation entities

Research groups

Affiliation entities